George Sellers
Stock Analyst at Stephens & Co.
(0.83)
# 2,785
Out of 4,414 analysts
49
Total ratings
26.32%
Success rate
-21.3%
Average return
Main Sectors:
11 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FNA Paragon 28 | Reiterates: Overweight | $18 | $9.77 | +84.24% | 3 | Apr 5, 2024 | |
CUTR Cutera | Reiterates: Overweight | $10 | $2.57 | +289.11% | 9 | Mar 22, 2024 | |
ANIK Anika Therapeutics | Reiterates: Equal-Weight | $22 | $27.59 | -20.26% | 5 | Mar 14, 2024 | |
ENOV Enovis | Initiates: Overweight | $72 | $52.13 | +38.12% | 1 | Feb 13, 2024 | |
ESTA Establishment Labs Holdings | Reiterates: Overweight | $47 | $49.50 | -5.05% | 6 | Jan 11, 2024 | |
APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.42 | +252.11% | 2 | Nov 10, 2023 | |
TFX Teleflex | Reiterates: Overweight | $275 | $198.73 | +38.38% | 8 | Nov 3, 2023 | |
VCEL Vericel | Reiterates: Overweight | $44 | $47.88 | -8.10% | 1 | Sep 21, 2023 | |
TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $10.71 | +133.43% | 4 | Sep 12, 2023 | |
STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $45.54 | +25.16% | 6 | Aug 14, 2023 | |
GKOS Glaukos | Reiterates: Overweight | $71 | $105.03 | -32.40% | 4 | May 8, 2023 |
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $9.77
Upside: +84.24%
Cutera
Mar 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $2.57
Upside: +289.11%
Anika Therapeutics
Mar 14, 2024
Reiterates: Equal-Weight
Price Target: $22
Current: $27.59
Upside: -20.26%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $52.13
Upside: +38.12%
Establishment Labs Holdings
Jan 11, 2024
Reiterates: Overweight
Price Target: $47
Current: $49.50
Upside: -5.05%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.42
Upside: +252.11%
Teleflex
Nov 3, 2023
Reiterates: Overweight
Price Target: $275
Current: $198.73
Upside: +38.38%
Vericel
Sep 21, 2023
Reiterates: Overweight
Price Target: $44
Current: $47.88
Upside: -8.10%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $10.71
Upside: +133.43%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $45.54
Upside: +25.16%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $105.03
Upside: -32.40%